Thus, incretins might represent a pathway potentially involved in the dysregulation of glucose metabolism in patients with PD and at high risk of T2D, and the gingival inflammation could potentially exert a detrimental action also on the incretin axis. The gene discussed is GCG; the disease is type 2 diabetes mellitus.